266 related articles for article (PubMed ID: 29659618)
1. Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5.
Chen Y; Liu X; Zhang F; Liao S; He X; Zhuo D; Huang H; Wu Y
PLoS One; 2018; 13(4):e0195844. PubMed ID: 29659618
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of the epithelial Ca2+ channel TRPV5 and TRPV6 in human renal cell carcinoma associated with vitamin D receptor.
Wu Y; Miyamoto T; Li K; Nakagomi H; Sawada N; Kira S; Kobayashi H; Zakohji H; Tsuchida T; Fukazawa M; Araki I; Takeda M
J Urol; 2011 Dec; 186(6):2419-25. PubMed ID: 22019165
[TBL] [Abstract][Full Text] [Related]
3. MiR-125b promotes migration and invasion by targeting the vitamin D receptor in renal cell carcinoma.
He X; Liao S; Lu D; Zhang F; Sun Y; Wu Y
Int J Med Sci; 2021; 18(1):150-156. PubMed ID: 33390783
[No Abstract] [Full Text] [Related]
4. MicroRNA-590-5p regulates cell viability, apoptosis, migration and invasion of renal cell carcinoma cell lines through targeting ARHGAP24.
Wang L; Wei WQ; Wu ZY; Wang GC
Mol Biosyst; 2017 Nov; 13(12):2564-2573. PubMed ID: 29019371
[TBL] [Abstract][Full Text] [Related]
5. Jam3 promotes migration and suppresses apoptosis of renal carcinoma cell lines.
Li X; Yin A; Zhang W; Zhao F; Lv J; Lv J; Sun J
Int J Mol Med; 2018 Nov; 42(5):2923-2929. PubMed ID: 30226554
[TBL] [Abstract][Full Text] [Related]
6. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
Wang H; Chen B; Duan B; Zheng J; Wu X
Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
[TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNA LOC648987 Promotes Proliferation and Metastasis of Renal Cell Carcinoma by Regulating Epithelial-Mesenchymal Transition.
Su Y; Zhou L; Yu Q; Lu J; Liu W
Technol Cancer Res Treat; 2021; 20():1533033821997834. PubMed ID: 33858283
[TBL] [Abstract][Full Text] [Related]
8. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
9. CARD10 promotes the progression of renal cell carcinoma by regulating the NF‑κB signaling pathway.
Peng L; He K; Cao Z; Bi L; Yu D; Wang Q; Wang J
Mol Med Rep; 2020 Jan; 21(1):329-337. PubMed ID: 31939627
[TBL] [Abstract][Full Text] [Related]
10. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
Li G; Chong T; Xiang X; Yang J; Li H
Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
[TBL] [Abstract][Full Text] [Related]
12. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
[TBL] [Abstract][Full Text] [Related]
13. Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.
Zhang R; Zhang W; Xu B; Lv C; Hou J; Zhang G
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):695-702. PubMed ID: 32138544
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑212 inhibits the proliferation and invasion of human renal cell carcinoma by targeting FOXA1.
Tong Z; Meng X; Wang J; Wang L
Mol Med Rep; 2018 Jan; 17(1):1361-1367. PubMed ID: 29115609
[TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
[TBL] [Abstract][Full Text] [Related]
16. Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.
Yu CP; Ho JY; Huang YT; Cha TL; Sun GH; Yu DS; Chang FW; Chen SP; Hsu RJ
PLoS One; 2013; 8(2):e56667. PubMed ID: 23460808
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-delivered microRNA targeting the vitamin D receptor reduces intracellular Ca²⁺ concentrations by regulating the expression of Ca²⁺-transport proteins in renal epithelial cells.
Xi Q; Wang S; Ye Z; Liu J; Yu X; Zhu Z; Su S; Bai J; Li C
BJU Int; 2011 Apr; 107(8):1314-9. PubMed ID: 20553254
[TBL] [Abstract][Full Text] [Related]
18. Ropivacaine suppresses the progression of renal cell carcinoma through regulating the lncRNA RMRP/EZH2/CCDC65 axis.
Xiong Y; Zheng X; Deng H
Daru; 2024 Jun; 32(1):121-132. PubMed ID: 38008820
[TBL] [Abstract][Full Text] [Related]
19. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
[TBL] [Abstract][Full Text] [Related]
20. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
Huang Z; Hua Y; Tian Y; Qin C; Qian J; Bao M; Liu Y; Wang S; Cao Q; Ju X; Wang Z; Gu M
Oncol Rep; 2018 Jun; 39(6):2996-3006. PubMed ID: 29693182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]